COVANCE $75.30

down -0.15


23/5/2013 09:23 AM  |  NYSE : CVD  |  Industries : Professional, Scientific, and Technical Services / Scientific Research and Development Services
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 65% - CVD has outperformed the S&P 500 by 41%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by

Ticker Name Weight % Change
No ETF alternatives available.


People viewing CVD also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ADEC ALTERNATIVE ENERGY 219.0 +1.00%
DNAG DNA PRINT GENOMICS 63.2K +1.00%
GNLK GENELINK 5.0K +0.29%
TNGN TENGION 2.1K +0.10%
OOIL ORIGINOIL 1.2K +0.01%
View All

CVD Stock Analysis

  1.

    The “Healthy” Play In Contract Research Organizations

    (CVD,ICLR,PXRL,AMRI,MRK,CRL,CG,JPM,BMY,PFE )
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1.

    Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
  2.

    5 Key Factors That Move The Currency Market

    Take Advantage of Boris Schlossberg & Kathy Lien’s Expertise, and Start Profiting Today!
  3.

    Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
Marketplace
Trading Center